PMXSF (Syntara) Other Current Receivables: $-0.49 Mil (As of Dec. 2025)


PMXSF Syntara Ltd PMXSF
13 GF Score
Price $0.03
! 1 Warning Sign
View Full Analysis

What is Syntara Other Current Receivables?

Syntara PMXSF 13 Other Current Receivables is $-0.49 Mil as of Dec. 2025. GuruFocus rates PMXSF with a GF Score™ of 13/100. The stock has 1 warning sign investors should review.

Syntara's Other Current Receivables for the quarter that ended in Dec. 2025 was $-0.49 Mil.

Syntara's quarterly Other Current Receivables increased from Dec. 2024 ($0.00 Mil) to Jun. 2025 ($3.68 Mil) but then stayed the same from Jun. 2025 ($3.68 Mil) to Dec. 2025 ($-0.49 Mil).

Syntara's annual Other Current Receivables declined from Jun. 2023 ($4.36 Mil) to Jun. 2024 ($3.72 Mil) and declined from Jun. 2024 ($3.72 Mil) to Jun. 2025 ($3.68 Mil).

Syntara Other Current Receivables Related Terms

Syntara Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Syntara's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syntara Other Current Receivables Chart

Syntara Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 3.64 4.36 3.72 3.68

Syntara Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.72 0.00 3.68 -0.49
PMXSF
13GF Score
Syntara Ltd PMXSF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syntara Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $-0.49 Mil mean?
Syntara (PMXSF) has a Other Current Receivables of $-0.49 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Syntara and its competitors.
Is Syntara's Other Current Receivables too high?
Syntara's current Other Current Receivables is $-0.49 Mil. Overall, Syntara has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Syntara's Other Current Receivables compare to ZTS and UTHR?
Syntara's Other Current Receivables of $-0.49 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Syntara and its competitors. Syntara's current Other Current Receivables is $-0.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syntara stock overvalued right now?
Syntara (PMXSF) has a current Other Current Receivables of $-0.49 Mil. The current Other Current Receivables is $-0.49 Mil. Syntara's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Syntara (PMXSF), the current Other Current Receivables is $-0.49 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Syntara Business Description

Other Exchanges UUDA:GermanySNT:Australia
Address 20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring and neuroinflammation.
13GF Score

Get the complete analysis for PMXSF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price